caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1790734549

Huzefa BahrainD.O.

Medical OncologyBaltimore, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,012
Unique beneficiaries
—
Total services
166,327
Distinct HCPCS
40
Medicare payment
$2.1M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 114 Medical Oncology providers in MD — top quintile (cohort median 578).
REFERRAL NETWORK

Where Huzefa Bahrain's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 26 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2834,487
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
1301,154
FRANKLIN SQUARE HOSPITAL CENTER, INC1151,076
Michael Auerbach
Hematology-Oncology · Baltimore, MD
93792
Troy Brijbasi
Diagnostic Radiology · Baltimore, MD
29425
Thomas Smith
Dermatology · Baltimore, MD
2859
Blair Andrew
Diagnostic Radiology · Baltimore, MD
24202
NPI 122503154522124
Quest Diagnostics Nichols Institute, Inc.
Clinical Laboratory · Chantilly, VA
2283
Rodney Johnson
Cardiology · Baltimore, MD
2041
James Poulton
Dermatology · Baltimore, MD
1951
Hassan Kassamali
Cardiology · Baltimore, MD
1988
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
367
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
15
Brand share
33.2%
Top prescribed drugs
Anastrozole58 claims
Lenalidomide32 claims
Potassium Chloride31 claims
Duloxetine Hcl30 claims
Ondansetron Hcl24 claims
QUALITY · MIPS · 2024
Final MIPS score
0.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-9.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$29K
Payment records
173
By payment type
Honoraria$14K
Travel and Lodging$10K
Food and Beverage$4K
Education$372